Strengthening Strategic Collaboration with AGRF

Written By Ketim Technologies

Brisbane, Australia – November 5, 2025 – Ongoing collaboration continues to play a critical role in advancing Ketim’s biomarker discovery and translational pipeline.

At AusBiotech 2025, Dr. Clarissa Yates, joined AGRF Ltd representatives to discuss Ketim’s journey from biomarker discovery to clinical translation. The conversation highlighted the role of advanced Olink proteomics services in identifying key protein biomarkers underpinning Ketim’s predictive blood test for postpartum depression.

For more than two years, AGRF has supported Ketim’s research through high-quality omics services that enable robust biomarker validation and data generation. This collaboration reflects the importance of strategic partnerships in accelerating translational science.

Ketim looks forward to continuing its work with AGRF and broader industry partners to advance precision psychiatry into clinical practice.

Ketim Technologies

https://www.ketim.com.au
Previous

Innovation in Maternal Mental Health Recognised at the 2025 Queensland Pearcey Awards
Next

Precision Psychiatry Takes the Stage at AGTA2025